Use of appropriate breakpoints in antimicrobial surveillance studies
Clin Infect Dis
.
2002 Dec 1;35(11):1446-8; author reply 1448-9.
doi: 10.1086/344186.
Authors
Michael R Jacobs
,
Laura M Koeth
,
Peter C Appelbaum
PMID:
12439815
DOI:
10.1086/344186
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents / pharmacology*
Drug Resistance, Bacterial
Haemophilus influenzae / drug effects
Microbial Sensitivity Tests
Streptococcus pneumoniae / drug effects
Substances
Anti-Bacterial Agents